Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
3h
Hosted on MSNModerna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The SidelinesShares of Moderna Inc. (MRNA) are on track for a more than 12% weekly decline, with sentiment among retail traders turning ...
Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...
The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...
The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results